MarketPulse

cryoablation

2 articles
BenzingaBenzinga··Prnewswire

ASBrS Endorses Cryoablation for Low-Risk Breast Cancer, Boosting IceCure Medical

ASBrS endorses cryoablation for low-risk breast cancer, validating IceCure Medical's ProSense system cleared by FDA in October 2025.
ICCMbreast cancerFDA clearance
BenzingaBenzinga··Prnewswire

IceCure's Cryoablation Wins Independent Validation for Breast Fibroadenomas

IceCure's ProSense cryoablation achieved 92.9% volume reduction in independent breast fibroadenoma study, validating technology for a 63,000-patient annual U.S. market.
ICCMmedical deviceminimally invasive surgery